BioCentury
ARTICLE | Clinical News

Oxygent perflubron: Phase IIb started

May 21, 2007 7:00 AM UTC

ALLP began a double-blind, placebo-controlled, dose-escalation, French Phase IIb trial in 128 patients undergoing primary coronary artery bypass graft (CABG) surgery under cardiopulmonary bypass (CPB)...